LAG3 and neoplasm: The expression of LAG3 on tumor-infiltrating lymphocytes (TILs) in some CRC tissues, where positive expression is associated with advanced tumor staging, MSI-H, and poor prognosis, may serve as a potential prognostic marker for CRC (Xu et al., 2021).